Café

© 2026 Longbridge｜Terms of Service Privacy Policy

The concept of innovative drugs has strengthened again, with Staidson BioPharm rising over 15%, reaching a three-year high

The concept of innovative drugs has strengthened again, with Staidson BioPharm rising over 15%, reaching a three-year high

Zhitong

May 28, 2025 at 08:42 PM

In the morning session, Staidson BioPharm rose over 15%, reaching a new three-year high, while JENKEM, BrightGene, NKF, Sunshine Guojian Pharmaceutical, and InventisBio also saw significant gains

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Related Stocks

NKF

SH603707

-0.74%

Sunshine Guojian Pharmaceutical

SH688336

+0.30%

InventisBio

SH688382

+4.44%

LongbridgeAI